Keywords: essex, chemie, returns, rights, losec, perfudal/prevex, italy
Essex Chemie Returns Rights To Losec and Perfudal/Prevex In Italy and Spain
Article | 09 December 1998
Schering-Plough's subsidiary Essex Chemie has agreed to return therights to market Losec (omeprazole) and Perfudal/Prevex (felodipine) in Italy and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
